Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery

Conditions

Cancer

Keywords

elderly, cancer surgery, quality of life, empowerment, shared-decision

Brief summary

The aims of this study are to investigate whether patient empowerment, including information and decision-aids adapted to the risk and the need of the elderly patient, can improve outcome in an evidence-based modular pathway in terms of * shortened hospital stay by a reduced postoperative complication rate and * quality of life in elderly patients compared to control patients receiving standard of care.

Scholtz K, Borchers F, Mörgeli R, Krampe H, Schmidt M, Eckardt-Felmberg R, von Dossow V, Sehouli J, Stief CG, Pohrt A, Spies CD, PERATECS Group.

2024-05-231 citations

10.1016/j.ejso.2024.108421

Anticholinergic burden of long-term medication is an independent risk factor for the development of postoperative delirium: A clinical trial.

Mueller A, Spies CD, Eckardt R, Weiss B, Pohrt A, Wernecke KD, Schmidt M, PERATECS-Group.

2019-10-2432 citations

10.1016/j.jclinane.2019.109632

Risk factors for 30-day complications after cancer surgery in geriatric patients: a secondary analysis.

Scholtz K, Spies CD, Mörgeli R, Eckardt R, von Dossow V, Braun S, Sehouli J, Bahra M, Stief CG, Wernecke KD, Schmidt M, PERATECS Group.

2018-01-228 citations

10.1111/aas.13067

Patient Empowerment Improved Perioperative Quality of Care in Cancer Patients Aged ≥ 65 Years – A Randomized Controlled Trial

Maren Schmidt, Rahel Eckardt, Kathrin Scholtz, Bruno Neuner, Vera von Dossow‐Hanfstingl et al. (10 authors)

PLoS ONE2015-09-1788 citations

10.1371/journal.pone.0137824

Interventions

BEHAVIORALInformation

Booklet, motivational interviewing, brief advice

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* Patients aged 65 years and older with abdominal, thoracical or urogenital cancer scheduled for surgery * Offered patient information and written informed consent * Confirmed cancer diagnosis via histology * Mini Mental state \> 23 * Life-expectance \> 2 months

Exclusion criteria

* Participation in another trial according to the German Drug Law 7 days to and 7 days after the operation during the study * No informed consent * Emergency patients * Lacking willingness to save and hand out data within the study * Accommodation in an institution due to an official or judicial order * Concurrent malignancies * Insufficient knowledge of the German language * In case of the inclusion of a PERATECS - study patient in an adjuvant therapy study during the study period, the patient will be excluded from the PERATECS-study

Design outcomes

Primary

Measure	Time frame
Length of hospital stay	within the first month
Quality of life	within the first year

Secondary

Measure	Time frame	Description
Overall mortality	within one year	—
Readmission rate	within the first three months	—
Stress	within the first month	Stress induced by postoperative pain, lack of mobilization and PONV.
Depression	within the first year	—
Short-term complications	within the first months	—

Countries

Germany

Outcome results

None listed